OrthoDx is an Australian company established by doctors for doctors, with a commitment to changing the future of orthopaedic diagnostics through genomics. Using proprietary biomarkers and existing PCR technology, OrthoDx has developed Synvichor™, a world-first genomic PCR test that is able to differentiate between infectious and non-infectious joint pain in a matter of hours. OrthoDx have harnessed the power of the human immune system to translate key clinical information about the body’s response to infection, rapidly and reliably.
| Website | http://www.orthodx.com.au |
| Employees | 8 (3 on RocketReach) |
| Founded | 2019 |
| Technologies |
JavaScript
,
HTML
,
Twitter
+8 more
(view full list)
|
| Industry | Biotechnology Research |
| Keywords | Orthopedic Diagnostics, Genomics, Biomarkers, Pcr Technology, Orthopedic Surgery, Bone Health, Joint Health, Musculoskeletal Health, Medical Diagnostics, Precision Medicine, Genetic Testing, Dna Testing, Healthcare Technology, Molecular Diagnostics, Diagnostic Testing, Medical Devices, Clinical Diagnostics, Health Diagnostics, Disease Diagnostics, Orthopedics |
| Competitors | Siemens, Roche, Thermo Fisher Scientific, Abbott, BD, Quest Diagnostics, Hologic, Inc., Cepheid, bioMérieux, Ortho Clinical Diagnostics - ANZ +42 more (view full list) |
Looking for a particular OrthoDx employee's phone or email?
Scott Gilroy is the Chief Operations Officer of OrthoDx.
3 people are employed at OrthoDx.
OrthoDx is based in Sydney, New South Wales.